"The highest frequency of resistance in vitro occured for etoposid, gemcitabin and paclitaxel and the most effective chemotherapeutical agents were cisplatinum and topotecan. Cisplatin had the lowest incidence of drug resistance in vitro than carboplatin."@en . "75" . "285233" . . . "Tom\u0161ov\u00E1, Mark\u00E9ta" . "\u0160pa\u010Dek, Ji\u0159\u00ED" . "RIV/00216208:11150/10:10079137" . "8"^^ . . . . "To\u0161ner, Jind\u0159ich" . . . . "Sedl\u00E1kov\u00E1, Iva" . . "Rezistence/sensitivita in vitro u pacientek s karcinomem ovaria" . "P(NS9737)" . . "Rezistence/sensitivita in vitro u pacientek s karcinomem ovaria"@cs . "8"^^ . "RIV/00216208:11150/10:10079137!RIV11-MZ0-11150___" . "Ceska Gynekologie" . "3" . . . . "CZ - \u010Cesk\u00E1 republika" . "\u0160kapinec, Peter" . "Brigulov\u00E1, Kate\u0159ina" . "Resistance/sensitivity in vitro in ovarian cancer patients"@en . . "11150" . . "Nejvy\u0161\u0161\u00ED rezistenci in vitro pomoc\u00ED MTT testu jsme zjistili u gemcitabinu, etoposidu a paklitaxelu a nejni\u017E\u0161\u00ED rezistenci u cisplatiny a topotekanu. Karboplatina vykazovala rezistenci \u010Dast\u011Bji ne\u017E cisplatina." . . "[C1C21524E87A]" . "Rezistence/sensitivita in vitro u pacientek s karcinomem ovaria"@cs . . "1210-7832" . "6"^^ . "Rezistence/sensitivita in vitro u pacientek s karcinomem ovaria" . "\u010Cervinka, Miroslav" . . "Nejvy\u0161\u0161\u00ED rezistenci in vitro pomoc\u00ED MTT testu jsme zjistili u gemcitabinu, etoposidu a paklitaxelu a nejni\u017E\u0161\u00ED rezistenci u cisplatiny a topotekanu. Karboplatina vykazovala rezistenci \u010Dast\u011Bji ne\u017E cisplatina."@cs . . "\u0158ez\u00E1\u010D, Adam" . . "Resistance/sensitivity in vitro in ovarian cancer patients"@en . . . . "MTT assay; chemotherapeutic agent; sensitivity; resistance; ovarian cancer"@en . .